ACIP recommendation for COVID booster for children

Translate to Spanish or other 102 languages!

“We applaud the Advisory Committee on Immunization Practices (ACIP) for their thoughtful deliberations and recommendation supporting that children ages 5-11 should receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine, at least five months after completion of the primary series. Image or illustration purposes
“We applaud the Advisory Committee on Immunization Practices (ACIP) for their thoughtful deliberations and recommendation supporting that children ages 5-11 should receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine, at least five months after completion of the primary series. Image or illustration purposes

Mega Doctor News

- Advertisement -
Gerald E. Harmon, MD
President, American Medical Association
Courtesy Image

The following statement is attributable to:
Gerald E. Harmon, MD
President, American Medical Association

“We applaud the Advisory Committee on Immunization Practices (ACIP) for their thoughtful deliberations and recommendation supporting that children ages 5-11 should receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine, at least five months after completion of the primary series. Based on what we know from other age groups, vaccine effectiveness against SARS-CoV-2 infection declines over time and vaccine booster doses have been shown to increase protection against all outcomes. With the highly transmissible Omicron variant continuing to evolve, strengthened neutralizing antibodies from the booster dose provides an additional layer of protection.

“The scientific evidence is clear that the vaccines against COVID-19 are safe and remain effective in preventing hospitalization and severe disease. It is concerning that only one in three children between the ages of 5 and 11 in the United States have received two doses of the vaccine, in part because parents believe them to be at lower risk for severe disease than adults. But the Omicron variant brought about change that should alter that calculus. According to the Centers for Disease Control and Prevention (CDC), the highly transmissible variant not only sent more children to the hospital and ICU than previous waves, but children who were unvaccinated were twice as likely to be hospitalized as those were vaccinated.

- Advertisement -

“Against this backdrop, we continue to strongly urge those who are eligible to stay up to date on their COVID-19 vaccines, including booster doses, to protect themselves and their loved ones from severe complications, hospitalization, and death. We look forward to the deliberations of the FDA’s Vaccines and Related Biological Products Advisory Committee and the ACIP on COVID-19 vaccine for kids under the age of 5, as many families are anxiously awaiting a safe and effective vaccine for this population.”

“Anyone with questions about the vaccines should speak with their physician and review trusted resources, including getvaccineanswers.org.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.
- Advertisement -